166 related articles for article (PubMed ID: 17396687)
1. Panretinal photocoagulation and photodynamic therapy for anterior segment neovascularization secondary to ischemic central retinal vein occlusion.
Parodi MB; Friberg TR; Pedio M; Fiotti N; Di Stefano G; Ravalico G
Ophthalmic Surg Lasers Imaging; 2007; 38(2):94-9. PubMed ID: 17396687
[TBL] [Abstract][Full Text] [Related]
2. Panretinal cryopexy for the management of neovascularization of the iris.
Stefaniotou M; Paschides CA; Psilas K
Ophthalmologica; 1995; 209(3):141-4. PubMed ID: 7543193
[TBL] [Abstract][Full Text] [Related]
3. Ocular neovascularization associated with central and hemicentral retinal vein occlusion.
Hayreh SS; Zimmerman MB
Retina; 2012 Sep; 32(8):1553-65. PubMed ID: 22495331
[TBL] [Abstract][Full Text] [Related]
4. [Anti-VEGF therapy in the treatment of anterior segment neovascularization secondary to central retinal vein occlusion].
Kabesha TB; Glacet-Bernard A; Rostaqui O; Souied EH
J Fr Ophtalmol; 2015 May; 38(5):414-20. PubMed ID: 25956562
[TBL] [Abstract][Full Text] [Related]
5. Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study.
Hayreh SS; Klugman MR; Podhajsky P; Servais GE; Perkins ES
Graefes Arch Clin Exp Ophthalmol; 1990; 228(4):281-96. PubMed ID: 1698170
[TBL] [Abstract][Full Text] [Related]
6. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
Batioğlu F; Astam N; Ozmert E
Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
[TBL] [Abstract][Full Text] [Related]
7. Verteporfin photodynamic therapy for anterior segment neovascularization secondary to ischaemic central retinal vein occlusion.
Parodi MB; Iacono P; Ravalico G
Clin Exp Ophthalmol; 2008 Apr; 36(3):232-7. PubMed ID: 18412591
[TBL] [Abstract][Full Text] [Related]
8. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report.
Ophthalmology; 1995 Oct; 102(10):1434-44. PubMed ID: 9097789
[TBL] [Abstract][Full Text] [Related]
9. The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion.
Browning DJ; Scott AQ; Peterson CB; Warnock J; Zhang Z
Ophthalmology; 1998 May; 105(5):776-84. PubMed ID: 9593375
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
11. Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Arch Ophthalmol; 1997 Apr; 115(4):486-91. PubMed ID: 9109757
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy with verteporfin for anterior segment neovascularizations in neovascular glaucoma.
Parodi MB; Iacono P
Am J Ophthalmol; 2004 Jul; 138(1):157-8. PubMed ID: 15234305
[TBL] [Abstract][Full Text] [Related]
13. SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion.
Chan CK; Ip MS; Vanveldhuisen PC; Oden NL; Scott IU; Tolentino MJ; Blodi BA;
Ophthalmology; 2011 Jul; 118(7):1364-72. PubMed ID: 21440942
[TBL] [Abstract][Full Text] [Related]
14. Retinochoroidal collateral veins protect against anterior segment neovascularization after central retinal vein occlusion.
Fuller JJ; Mason JO; White MF; McGwin G; Emond TL; Feist RM
Arch Ophthalmol; 2003 Mar; 121(3):332-6. PubMed ID: 12617702
[TBL] [Abstract][Full Text] [Related]
15. Treatment of rubeosis iridis with photodynamic therapy with verteporfin--A new therapeutic and prophylactic option for patients with the risk of neovascular glaucoma?
Müller VA; Ruokonen P; Schellenbeck M; Hartmann C; Tetz M
Ophthalmic Res; 2003; 35(1):60-4. PubMed ID: 12566865
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of panretinal photocoagulation for neovascularization of the iris after central retinal artery obstruction.
Duker JS; Brown GC
Ophthalmology; 1989 Jan; 96(1):92-5. PubMed ID: 2465523
[TBL] [Abstract][Full Text] [Related]
17. A review of neovascular glaucoma. Etiopathogenesis and treatment.
Dumbrăveanu L; Cușnir V; Bobescu D
Rom J Ophthalmol; 2021; 65(4):315-329. PubMed ID: 35087972
[TBL] [Abstract][Full Text] [Related]
18. [Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion (report of 21 cases followed at Bukavu Eye Clinic from January 1 to December 31th, 2015)].
Kabesha TB; Kabesha D; Maloba V; Mwamba C; Chenge B; Mukalay A
J Fr Ophtalmol; 2017 Jan; 40(1):17-21. PubMed ID: 27884546
[TBL] [Abstract][Full Text] [Related]
19. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].
Douat J; Auriol S; Mahieu-Durringer L; Ancèle E; Pagot-Mathis V; Mathis A
J Fr Ophtalmol; 2009 Nov; 32(9):652-63. PubMed ID: 19892433
[TBL] [Abstract][Full Text] [Related]
20. [Results of laser coagulation of central retinal vein occlusion].
Lang GE
Klin Monbl Augenheilkd; 1993 Oct; 203(4):247-51. PubMed ID: 7509425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
